You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Danaher reported third-quarter core revenue growth excluding respiratory revenue of 5.5% and raised full-year 2026 adjusted diluted net EPS guidance to $8.57 to $8.62. It sees 4% to 5% core revenue growth excluding respiratory revenue for 2027.
Danaher Corporation reported third-quarter 2026 revenue of $6.6 billion, up 8.5%, net earnings of $1.2 billion and adjusted diluted EPS of $2.11, and raised full-year 2026 adjusted diluted EPS guidance to $8.57 to $8.62.
Danaher reported third-quarter revenues up 8.5% and core sales up 3.0%, with core sales excluding respiratory testing up 5.5%; nine-month operating margin rose 180 basis points to 19.8%. It acquired Masimo for approximately $9.8 billion on June 10, 2026.
Danaher appointed Daniel L. Comas and Robert M. Hershberg as directors on October 9, 2026, while Steven M. Rales and Mitchell P. Rales each waived rights to 500,000 Founder RSUs.
